BSX vs KFS · P/E 20, rev $10.65B vs rev $109.4M
Boston Scientific Corp (BSX) versus Kingsway Financial Services Inc (KFS) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Kingsway Financial Services Inc (KFS) is a asset management company listed on US.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported KFS revenue for 2024-12-31 was $109.4M. Net income was -$8.3M. Revenue was up 5.9% from 2023-12-31 to 2024-12-31. KFS currently screens at market cap $307.2M.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. KFS currently screens at market cap $307.2M.
Not investment advice. Open the BSX and KFS stock pages for the full models.
Not investment advice.